sulfinpyrazone has been researched along with Airway Obstruction in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steele, P | 1 |
| Ellis, JH | 1 |
| Genton, E | 1 |
1 other study available for sulfinpyrazone and Airway Obstruction
| Article | Year |
|---|---|
Platelet survival time in severe chronic airway obstruction.
Topics: Airway Obstruction; Blood Cell Count; Blood Platelets; Cell Survival; Chronic Disease; Humans; Hypox | 1975 |